G K Balasubramani
Overview
Explore the profile of G K Balasubramani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
3642
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zimmerman R, Nowalk M, Dauer K, Clarke L, Raviotta J, Balasubramani G
Vaccine
. 2023 Jul;
41(35):5134-5140.
PMID: 37474406
Background: Relative effectiveness of various vaccine formulations provide important input for vaccine policy decisions and provider purchasing decisions. We used electronic databases to conduct a test-negative case control study to...
12.
Bi Q, Dickerman B, Nguyen H, Martin E, Gaglani M, Wernli K, et al.
medRxiv
. 2023 Apr;
PMID: 37016669
Studies have reported that prior-season influenza vaccination is associated with higher risk of clinical influenza infection among vaccinees. This effect might arise from incomplete consideration of within-season waning and recent...
13.
Luciani L, Miller L, Zhai B, Clarke K, Hughes Kramer K, Schratz L, et al.
Open Forum Infect Dis
. 2023 Mar;
10(3):ofad095.
PMID: 36949873
Background: The ongoing circulation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a diagnostic challenge because symptoms of coronavirus disease 2019 (COVID-19) are difficult to distinguish from other respiratory...
14.
Zimmerman R, Dauer K, Clarke L, Nowalk M, Raviotta J, Balasubramani G
Hum Vaccin Immunother
. 2023 Feb;
19(1):2177461.
PMID: 36809982
Newer influenza vaccine formulations have entered the market, but real-world effectiveness studies are not widely conducted until there is sufficient uptake. We conducted a retrospective test-negative case-control study to determine...
15.
Nowalk M, Sax T, Susick M, Taylor L, Clarke L, Dauer K, et al.
Brain Behav Immun Health
. 2023 Jan;
28:100596.
PMID: 36713477
Background: Little is known about the effects of a mild SARS-CoV-2 infection on health-related quality of life. Methods: This prospective observational study of symptomatic adults (18-87 years) who sought outpatient...
16.
Gonzalez-Gonzalez L, Knickelbein J, Doft B, Balasubramani G, Wisniewski S
Int Ophthalmol
. 2022 Sep;
43(3):867-876.
PMID: 36103102
Background: To describe the incidence and factors predicting visual outcome in patients with infectious endophthalmitis following intravitreal anti-VEGF injection. Methods: Retrospective, single-site, cohort study. Patients with acute endophthalmitis within 6 ...
17.
Nowalk M, DAgostino H, Dauer K, Stiegler M, Zimmerman R, Balasubramani G
Vaccine
. 2022 Sep;
40(42):6187.
PMID: 36100491
No abstract available.
18.
Zimmerman R, Balasubramani G, DAgostino H, Clarke L, Yassin M, Middleton D, et al.
Influenza Other Respir Viruses
. 2022 Aug;
16(6):1133-1140.
PMID: 35996836
Background: Acute respiratory infections (ARIs) result in millions of illnesses and hundreds of thousands of hospitalizations annually in the United States. The responsible viruses include influenza, parainfluenza, human metapneumovirus, coronaviruses,...
19.
Nowalk M, DAgostino H, Dauer K, Stiegler M, Zimmerman R, Balasubramani G
Vaccine
. 2022 Jun;
40(31):4121-4127.
PMID: 35667912
Background: Numerous studies in the U.S. have made estimates of the RSV burden among adults that vary widely due to differences in methodology, reliance on influenza surveillance, which does not...
20.
Balasubramani G, Nowalk M, Eng H, Zimmerman R
Hum Vaccin Immunother
. 2022 Mar;
18(1):1958610.
PMID: 35271432
Respiratory syncytial virus (RSV) is becoming increasingly recognized as a serious threat to vulnerable population subgroups. This study describes the statistical analysis plan for a retrospective cohort study of adults...